August 26, 2020
Slideshow
Here: A summary of indicators for stress and anxiety in patients undergoing transplantation, and why it is important for psychiatrists to be aware of these factors.
October 13, 2017
Article
The authors review basic neuroendocrine function and the evidence base of hormonal contribution to psychiatric symptoms in PCOS, PMDD, and perimenopause. They also offer strategies for psychiatrists for both clinical assessment and management of women with neuroendocrine dysfunction.
September 25, 2017
Article
This article delineates the role of psychiatrists in preventing HIV transmission before and after HIV exposure through pre- and post-exposure prophylaxis.
June 26, 2017
Article
Here: a review of the definition of sexual harassment, its prevalence among physicians and medical students, its potential impact on physicians and trainees, and guidance about its management.
April 18, 2017
Article
Access to illicit drugs is now as easy as a few swipes on a smartphone. Here's a primer for clinicians who aren't well acquainted with this trend and who aren’t familiar with the many substances themselves.
December 26, 2016
Article
Here: a look at the associations between negative psychological states and CV health, physiologic and health behavior mechanisms, and ways to diagnose and treat depression and anxiety disorders.
October 25, 2016
Article
The authors focus on the psychiatric management of transplant recipients and the evaluation and care of living organ donors.
September 29, 2016
Article
Psychiatrists are playing an ever-increasing role in the evaluation and care of organ transplant candidates and living organ donors-before and after transplant.
July 26, 2016
Article
The authors parse myths and facts about decisional capacity, with the goal of preserving patients' dignity and autonomy and helping you mediate conflicts, meet bioethical challenges, and provide compassionate resolutions.
June 24, 2016
Article
To support patients with breast cancer, psychiatrists should be aware of possible medication interactions, psychiatric or neurologic adverse effects of treatment, and signs of disease progression--issues that are the focus here.